FIELD: medicine.
SUBSTANCE: invention relates to medicine. Said technical result is achieved by using a xenon clathrate compound for administering the amount of xenon required for prevention and treatment of the disease. Xenon clathrate is introduced into the gastrointestinal tract of the body through a carrier of the dosage form for ingestion.
EFFECT: invention aims at simplifying and easing the procedure for administering the required amount of xenon into the human body to provide a sufficient therapeutic effect.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PRODUCING PHARMACEUTICAL SUBSTANCE XENON HYDRATE (Xe·6HO) | 2022 |
|
RU2794771C1 |
| METHOD FOR CORRECTION OF HUMAN FUNCTIONAL STATE IN CONFINED SPACE | 2018 |
|
RU2712804C1 |
| METHOD FOR IMPROVING THE CONDITION OF THE SKIN AND SUBCUTANEOUS TISSUES | 2022 |
|
RU2789964C1 |
| GENERAL SOMATIC DISEASE XENOTHERAPY METHOD | 2006 |
|
RU2305565C1 |
| METHOD OF INCREASING DEGREE OF PENETRATION AND EFFECTIVENESS OF TOPICAL AGENTS WITH STABLE LONG-TERM CONTENT OF INERT GAS | 2023 |
|
RU2814767C1 |
| METHOD FOR IMPROVING TRANSDERMAL PERMEABILITY OF THERAPEUTIC OR COSMETIC TOPICAL PREPARATIONS, METHOD FOR DERMAL ADMINISTRATION OF LIQUID XENON | 2012 |
|
RU2506944C1 |
| METHOD FOR REDUCING INFLAMMATORY HYPERACTIVATION OF NEUTROPHILS | 2020 |
|
RU2758536C1 |
| XENON APPLICATION FOR CORRECTION OF ORGANISM LESIONS ASSOCIATED WITH ANTIOXIDANT STATUS DISORDER | 2006 |
|
RU2346695C2 |
| METHOD FOR INCREASING THE LEVEL OF CONSCIOUSNESS OF PATIENTS WITH PROLONGED IMPAIRMENT OF CONSCIOUSNESS AFTER TRAUMATIC BRAIN INJURY | 2022 |
|
RU2789004C1 |
| BIOLOGICALLY ACTIVE DAIRY PRODUCT | 2007 |
|
RU2341095C1 |
